Carica Papaya Extract 1100mg Capsules

Carica papaya leaf extract has been traditionally used across South and Southeast Asia for febrile illness management, and its platelet-modulating effects have been validated in multiple controlled clinical trials. MSVD Labs’ Carica Papaya Extract 1100mg Capsules provide a high-potency standardised extract for immune support, platelet health, and general antioxidant protection. The active compounds in papaya leaf extract include flavonoids (quercetin, kaempferol), alkaloids (carpaine, pseudocarpaine), phenolic acids, and proteolytic enzymes (papain, chymopapain). Clinical trials in dengue fever patients found that papaya leaf extract supplementation significantly accelerated platelet recovery compared to placebo, reducing hospitalisation duration and improving clinical outcomes. These findings have led to papaya leaf extract being widely recommended as adjunct support during dengue management by practitioners across India. Beyond dengue support, papaya leaf extract demonstrates hepatoprotective properties, antioxidant activity measured by DPPH and FRAP assays, and anti-inflammatory effects through NF-κB pathway inhibition. The high natural vitamin C content in papaya extract contributes direct antioxidant defence and supports immune cell function year-round. MSVD Labs uses a concentrated aqueous papaya leaf extract standardised by HPLC for active marker compounds. Each batch undergoes testing for heavy metals, pesticide residues, and microbial safety — critical quality parameters for botanical extracts where supply chain contamination risks are elevated. Manufactured at WHO-GMP and ISO 9001:2015 certified facility in Surat, Gujarat. Available in 500mg, 750mg, and 1100mg per capsule strengths. Seasonal demand management with supply continuity guaranteed. Private label and third-party manufacturing with full regulatory documentation.